Investigation of OneSpan Inc.
OneSpan Inc. (OSPN) Overstated its Revenue OneSpan Inc. may have made false and misleading statements regarding the Company’s internal policies and downplayed the likely negative impact on its profits.
OneSpan Inc. (OSPN) Overstated its Revenue OneSpan Inc. may have made false and misleading statements regarding the Company’s internal policies and downplayed the likely negative impact on its profits.
Kadmon Holdings, Inc. (KDMN) Misled Investors Regarding its New Drug Submission for its Lead Drug Candidate On September 30, 2020, Kadmon announced the submission of a New Drug Application (“NDA”)
Plug Power, Inc. (PLUG) Misled Shareholders Regarding its Internal Controls Over Financial Reporting On November 9, 2020, Power Plug reported its third quarter 2020 financial results in a letter posted
Workhorse Group, Inc. (WKHS) Misled Shareholders About Its Ability to Obtain a Delivery Vehicle Contract With the USPS Workhorse Group was vying for the USPS’s Next Generation Delivery Vehicle project,
3D Systems Corp. (DDD) Lacked Proper Internal Controls Over Financial Reporting Throughout the class period, 3D Systems attested to the accuracy of its financial reporting and disclosure controls and
SOS Limited (SOS) Misled Investors Regarding the True Nature of its Business Critical to SOS’s transition into cryptocurrency mining were the Company’s claims to have entered into an agreement with
Repro Med Systems, Inc. d/b/a Koru Medical Systems (KRMD) Failed to Disclose its Use of Allowances to Incentivize Growth On August 4, 2020, KORU announced strong second quarter financial results.
Repro Med Systems, Inc. d/b/a Koru Medical Systems (KRMD) Failed to Disclose its Use of Allowances to Incentivize Growth On August 4, 2020, KORU announced strong second quarter financial results.
BELLUS Health Inc. (BLU) Misled Investors About its Lead Product Candidate BELLUS common stock began trading on September 5, 2019. In its Registration Statement, BELLUS touted the efficacy of
Attorney Advertising. Past results do not guarantee a similar outcome.
5060 Shoreham Pl., Ste. 300 San Diego, CA 92122
Disclaimer | Site Map | Privacy Policy
© 2024 – Robbins LLP
Stock Watch members receive free investment monitoring and notifications.